• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高 Child-Pugh 和 CRUB65 评分可预测 COVID-19 失代偿性肝硬化患者的死亡率:一项 23 中心回顾性研究。

High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study.

机构信息

Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.

Department of Gastroenterology, The Third XiangYa Hospital Central South University, Changsha, Hunan, China.

出版信息

Virulence. 2021 Dec;12(1):1199-1208. doi: 10.1080/21505594.2021.1909894.

DOI:10.1080/21505594.2021.1909894
PMID:33870852
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8078510/
Abstract

: COVID-19 has rapidly become a major health emergency worldwide. The characteristic, outcome, and risk factor of COVID-19 in patients with decompensated cirrhosis remain unclear.: Medical records were collected from 23 Chinese hospitals. Patients with decompensated cirrhosis and age- and sex-matched non-liver disease patients were enrolled with 1:4 ratio using stratified sampling.: There were more comorbidities with higher Chalson Complication Index (p < 0.001), higher proportion of patients having gastrointestinal bleeding, jaundice, ascites, and diarrhea among those patients (p < 0.05) and in decompensated cirrhosis patients. Mortality (p < 0.05) and the proportion of severe ill (p < 0.001) were significantly high among those patients. Patients in severe ill subgroup had higher mortality (p < 0.001), MELD, and CRUB65 score but lower lymphocytes count. Besides, this subgroup had larger proportion of patients with abnormal (PT), activated partial thromboplatin time (APTT), D-Dimer, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBL) and Creatinine (Cr) (p < 0.05). Multivariate logistic regression for severity shown that MELD and CRUB65 score reached significance. Higher Child-Pugh and CRUB65 scores were found among non-survival cases and multivariate logistic regression further inferred risk factors for adverse outcome. Receiver Operating Characteristic (ROC) curves also provided remarkable demonstrations for the predictive ability of Child-Pugh and CRUB65 scores.: COVID-19 patients with cirrhosis had larger proportion of more severely disease and higher mortality. MELD and CRUB65 score at hospital admission may predict COVID-19 severity while Child-Pugh and CRUB65 score were highly associated with non-survival among those patients.

摘要

: COVID-19 已迅速成为全球范围内的重大卫生紧急事件。失代偿期肝硬化患者 COVID-19 的特征、结局和危险因素仍不清楚。: 从 23 家中国医院收集病历。采用分层抽样,按 1:4 的比例纳入失代偿期肝硬化患者和年龄、性别匹配的非肝脏疾病患者。: 与非肝脏疾病患者相比,失代偿期肝硬化患者合并症更多,Chalson 并发症指数更高(p < 0.001),胃肠道出血、黄疸、腹水和腹泻的患者比例更高(p < 0.05)。失代偿期肝硬化患者的死亡率(p < 0.05)和重症患者比例(p < 0.001)显著较高。重症患者亚组死亡率更高(p < 0.001)、MELD 和 CRUB65 评分更高,但淋巴细胞计数更低。此外,该亚组患者中 PT、活化部分凝血活酶时间(APTT)、D-二聚体、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、总胆红素(TBL)和肌酐(Cr)异常的患者比例更高(p < 0.05)。严重程度的多变量逻辑回归显示 MELD 和 CRUB65 评分有统计学意义。非存活病例的 Child-Pugh 和 CRUB65 评分更高,多变量逻辑回归进一步推断出不良结局的危险因素。受试者工作特征(ROC)曲线也为 Child-Pugh 和 CRUB65 评分的预测能力提供了显著证据。: COVID-19 合并肝硬化患者疾病更严重、死亡率更高。入院时的 MELD 和 CRUB65 评分可能预测 COVID-19 的严重程度,而 Child-Pugh 和 CRUB65 评分与这些患者的非存活高度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/8078510/a144d3928fab/KVIR_A_1909894_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/8078510/fc668edec2f1/KVIR_A_1909894_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/8078510/a144d3928fab/KVIR_A_1909894_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/8078510/fc668edec2f1/KVIR_A_1909894_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d017/8078510/a144d3928fab/KVIR_A_1909894_F0002_OC.jpg

相似文献

1
High Child-Pugh and CRUB65 scores predict mortality of decompensated cirrhosis patients with COVID-19: A 23-center, retrospective study.高 Child-Pugh 和 CRUB65 评分可预测 COVID-19 失代偿性肝硬化患者的死亡率:一项 23 中心回顾性研究。
Virulence. 2021 Dec;12(1):1199-1208. doi: 10.1080/21505594.2021.1909894.
2
MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis.终末期肝病模型(MELD)评分与Child-Pugh评分及肌酐校正的Child-Pugh评分在预测失代偿期肝硬化患者生存率方面的比较
World J Gastroenterol. 2005 May 28;11(20):3099-104. doi: 10.3748/wjg.v11.i20.3099.
3
Development and Validation of CAGIB Score for Evaluating the Prognosis of Cirrhosis with Acute Gastrointestinal Bleeding: A Retrospective Multicenter Study.CAGIB 评分用于评估急性胃肠道出血伴肝硬化患者预后的开发和验证:一项回顾性多中心研究。
Adv Ther. 2019 Nov;36(11):3211-3220. doi: 10.1007/s12325-019-01083-5. Epub 2019 Sep 11.
4
Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.严重急性呼吸综合征冠状病毒 2 死亡率的肝脏预测因子:初始天门冬氨酸氨基转移酶/丙氨酸氨基转移酶和预先存在的肝硬化的作用。
Hepatol Commun. 2020 Dec 5;5(3):424-433. doi: 10.1002/hep4.1648. eCollection 2021 Mar.
5
Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.与原始Child Pugh评分相比,评估肌酐修正的Child Pugh评分对失代偿期肝硬化患者短期预后的预测价值。
J Ayub Med Coll Abbottabad. 2009 Apr-Jun;21(2):64-7.
6
A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.肝硬化患者不同预后模型的修订范围:当前与未来展望,埃及的经验
Arab J Gastroenterol. 2013 Dec;14(4):158-64. doi: 10.1016/j.ajg.2013.08.007. Epub 2013 Sep 29.
7
Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study.识别肝硬化合并急性静脉曲张出血患者中早期 TIPS 的最佳人选:一项多中心观察性研究。
Gut. 2019 Jul;68(7):1297-1310. doi: 10.1136/gutjnl-2018-317057. Epub 2018 Nov 10.
8
Multicenter External Validation of Risk Stratification Criteria for Patients With Variceal Bleeding.多中心验证静脉曲张出血患者风险分层标准。
Clin Gastroenterol Hepatol. 2018 Jan;16(1):132-139.e8. doi: 10.1016/j.cgh.2017.04.042. Epub 2017 May 10.
9
Serum lactate level predicts 6-months mortality in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective study.血清乳酸水平可预测乙型肝炎病毒相关失代偿性肝硬化患者 6 个月的死亡率:一项回顾性研究。
Epidemiol Infect. 2021 Jan 5;149:e26. doi: 10.1017/S0950268820003143.
10
Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study.白蛋白-胆红素评分预测肝硬化急性上消化道出血患者院内死亡率的回顾性研究
Turk J Gastroenterol. 2016 Mar;27(2):180-6. doi: 10.5152/tjg.2016.15502.

引用本文的文献

1
Predicting in-hospital mortality in patients with alcoholic cirrhosis complicated by severe acute kidney injury: development and validation of an explainable machine learning model.预测酒精性肝硬化合并严重急性肾损伤患者的院内死亡率:一种可解释机器学习模型的开发与验证
Front Med (Lausanne). 2025 May 8;12:1570928. doi: 10.3389/fmed.2025.1570928. eCollection 2025.
2
Clinical manifestations of SARS-CoV-2 Omicron infection is associated with the stage of liver cirrhosis.新型冠状病毒奥密克戎变异株感染的临床表现与肝硬化分期相关。
BMC Infect Dis. 2025 Apr 29;25(1):630. doi: 10.1186/s12879-025-11040-z.
3
Liver Disease Undernutrition Screening Tool Questionnaire Predicts Decompensation and Mortality in Cirrhotic Outpatients with Portal Hypertension.

本文引用的文献

1
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry.患有慢性肝病和肝硬化的患者感染新型冠状病毒的死亡率很高:一项国际登记处的初步结果
J Hepatol. 2020 Sep;73(3):705-708. doi: 10.1016/j.jhep.2020.05.013. Epub 2020 May 21.
2
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.SARS-CoV-2 感染肝脏直接导致 COVID-19 患者肝损伤。
J Hepatol. 2020 Oct;73(4):807-816. doi: 10.1016/j.jhep.2020.05.002. Epub 2020 May 11.
3
Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.
肝脏疾病营养不良筛查工具问卷可预测门脉高压性肝硬化门诊患者的失代偿和死亡。
Nutrients. 2023 Aug 29;15(17):3780. doi: 10.3390/nu15173780.
4
COVID-19 in patients with pre-existing chronic liver disease - predictors of outcomes.患有慢性肝病的COVID-19患者——预后预测因素
World J Virol. 2023 Jan 25;12(1):30-43. doi: 10.5501/wjv.v12.i1.30.
5
Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2.奥密克戎变异株感染的 COVID-19 患者的肝损伤。
Front Public Health. 2022 Nov 18;10:1049006. doi: 10.3389/fpubh.2022.1049006. eCollection 2022.
6
COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management.COVID-19 相关肝损伤:临床特征、病理生理机制和治疗管理。
Biomed Pharmacother. 2022 Oct;154:113568. doi: 10.1016/j.biopha.2022.113568. Epub 2022 Aug 17.
7
Predictors of Severity and Mortality in Chronic Liver Disease Patients With COVID-19 During the Second Wave of the Pandemic in India.印度第二波疫情期间新冠肺炎慢性肝病患者严重程度和死亡率的预测因素
Cureus. 2022 Jan 3;14(1):e20891. doi: 10.7759/cureus.20891. eCollection 2022 Jan.
合并肝硬化的新型冠状病毒肺炎患者的临床病程及死亡危险因素:一项多中心队列研究
Gut. 2021 Feb;70(2):433-436. doi: 10.1136/gutjnl-2020-321666. Epub 2020 May 20.
4
AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.美国胃肠病学会关于新型冠状病毒肺炎胃肠道和肝脏表现的快速综述、国际数据的荟萃分析以及新型冠状病毒肺炎患者咨询管理建议
Gastroenterology. 2020 Jul;159(1):320-334.e27. doi: 10.1053/j.gastro.2020.05.001. Epub 2020 May 11.
5
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.在新型冠状病毒肺炎(COVID-19)的治疗中应注意静脉血栓栓塞的预防。
Lancet Haematol. 2020 May;7(5):e362-e363. doi: 10.1016/S2352-3026(20)30109-5. Epub 2020 Apr 9.
6
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响:一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
7
Prevention of SARS-CoV-2 infection in patients with decompensated cirrhosis.失代偿期肝硬化患者中新型冠状病毒2型感染的预防
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):528-529. doi: 10.1016/S2468-1253(20)30080-7. Epub 2020 Mar 17.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Liver injury during highly pathogenic human coronavirus infections.高致病性人冠状病毒感染期间的肝损伤。
Liver Int. 2020 May;40(5):998-1004. doi: 10.1111/liv.14435. Epub 2020 Mar 30.
10
Liver injury in COVID-19: management and challenges.新型冠状病毒肺炎中的肝损伤:管理与挑战
Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.